Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico
World | January 25, 2021 11:31 ISTZydus Cadila, which is part of Cadila Healthcare, said: "Patients infected with COVID-19 have been reported to display signs of 'Hypoxia' leading to organ failure and death despite the use of antivirals, anti-inflammatory drugs or ventilators.